Skip to main content
Premium Trial:

Request an Annual Quote

New York State Grants Clinical Lab Permit to Empire Genomics

NEW YORK (GenomeWeb) – Cancer diagnostics company Empire Genomics announced today that it has received approval from New York State to offer molecular and cellular tumor marker testing through the state's Clinical Laboratory Evaluation Program (CLEP).

The company plans to offer genetic testing and molecular diagnostics to help physicians make treatment decisions for cancer patients. The CLEP program evaluates a clinical lab's ability to accurately and reliably deliver test results.

"The addition of molecular testing solidifies our test menu, allowing us to offer a more complete range of testing needed for personalized diagnostics and therapeutics," said COO John Rushton in a statement.

In December, the firm reported receiving CE Marking for several of its products including fluorescent in situ hybridization probes and karyotyping media.

The Scan

Driving Malaria-Carrying Mosquitoes Down

Researchers from the UK and Italy have tested a gene drive for mosquitoes to limit the spread of malaria, NPR reports.

Office Space to Lab Space

The New York Times writes that some empty office spaces are transforming into lab spaces.

Prion Pause to Investigate

Science reports that a moratorium on prion research has been imposed at French public research institutions.

Genome Research Papers on Gut Microbe Antibiotic Response, Single-Cell RNA-Seq Clues to Metabolism, More

In Genome Research this week: gut microbial response to antibiotic treatment, approach to gauge metabolic features from single-cell RNA sequencing, and more.